To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene GTSE1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
350 representative clones for gene GTSE1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DC351247 brain GTSE1.a 1 to 549 1 to 549   tiling clone,   549/549
(100 %)
0 diff
(100 %id)
DA736212   GTSE1.a 22 to 730 2 to 709   tiling clone, capped   708/708
(100 %)
4 diff
(99.5 %id)
CN371330 embryonic stem cells, DMSO-treated H9 cellline GTSE1.a 23 to 488 8 to 473       466/473
(98 %)
7 diff
(98.6 %id)
CN371331 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells GTSE1.a 28 to 393 11 to 376       366/376
(97 %)
6 diff
(98.5 %id)
DB086298 testis GTSE1.a 83 to 644 2 to 563   capped   562/562
(100 %)
0 diff
(100 %id)
TI_158433181   GTSE1.a 87 to 497 482 to 72       411/957
(42 %)
0 diff
(100 %id)
DA609786   GTSE1.a 121 to 672 2 to 551   capped   550/554
(99 %)
5 diff
(99.1 %id)
DA509279 brain GTSE1.a 133 to 703 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
DB080859 testis GTSE1.a 163 to 490 2 to 329   capped   328/328
(100 %)
0 diff
(100 %id)
DB452768 testis GTSE1.a 227 to 704 1 to 478       478/478
(100 %)
1 diff
(99.8 %id)
DB457302 testis GTSE1.a 247 to 714 1 to 468   tiling clone,   468/468
(100 %)
0 diff
(100 %id)
DB368653   GTSE1.a 2535 to 3050 516 to 1   tiling clone,   514/516
(99 %)
11 diff
(97.9 %id)
NM_016426.6   GTSE1.b 1 to 3110 2 to 3111 W525R RefSeq, AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 3111/3111
(100 %)
1 diff
(100.0 %id)
DB091686 testis GTSE1.b 1 to 556 2 to 557   tiling clone, capped   556/556
(100 %)
0 diff
(100 %id)
DA697736   GTSE1.b 58 to 625 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
DA734138   GTSE1.b 67 to 742 2 to 682   capped   681/691
(98 %)
10 diff
(98.6 %id)
BC075828 Brain, neuroblastoma GTSE1.b 99 to 2785 1 to 2687 P23S W525R available from MGC, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 2687/2687
(100 %)
2 diff
(100.0 %id)
BP280465   GTSE1.b 115 to 714 1 to 599       599/599
(100 %)
3 diff
(99.5 %id)
DA649421   GTSE1.b 116 to 651 2 to 537   capped   536/536
(100 %)
1 diff
(99.9 %id)
BX956794   GTSE1.b 134 to 767 1 to 634       634/634
(100 %)
1 diff
(99.9 %id)
BP363663 lung GTSE1.b 142 to 724 1 to 583       583/583
(100 %)
1 diff
(99.9 %id)
DA752280   GTSE1.b 143 to 709 2 to 567   capped   566/566
(100 %)
2 diff
(99.7 %id)
BP356212   GTSE1.b 146 to 732 1 to 587       587/587
(100 %)
0 diff
(100 %id)
DA651423   GTSE1.b 147 to 686 2 to 541   capped   540/540
(100 %)
2 diff
(99.7 %id)
BG718574 testis GTSE1.b 154 to 799 1 to 657       652/657
(99 %)
17 diff
(97.5 %id)
DB018523 esophageal, tumor tissue GTSE1.b 155 to 730 2 to 577   capped   576/576
(100 %)
0 diff
(100 %id)
BP364794 lung GTSE1.b 167 to 754 1 to 587       587/587
(100 %)
5 diff
(99.2 %id)
DA504433 brain GTSE1.b 172 to 676 2 to 509   capped   508/508
(100 %)
5 diff
(99.1 %id)
AK025563   GTSE1.b 173 to 2785 1 to 2613 M154V N325D K474R W525R available from FLJ, AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 2613/2613
(100 %)
5 diff
(99.9 %id)
AK222806 Liver GTSE1.b 173 to 2680 1 to 2508 M154V N325D K474R W525R     2508/2508
(100 %)
5 diff
(99.9 %id)
AK315550 placenta GTSE1.b 174 to 2431 1 to 2258 W525R tiling clone,   2258/2258
(100 %)
1 diff
(100.0 %id)
DB447389 testis GTSE1.b 174 to 609 1 to 436       436/436
(100 %)
3 diff
(99.4 %id)
BP242436 Liver GTSE1.b 174 to 754 1 to 581       581/581
(100 %)
1 diff
(99.9 %id)
BP352111   GTSE1.b 174 to 753 1 to 581       581/581
(100 %)
2 diff
(99.7 %id)
BP364179 lung GTSE1.b 174 to 771 1 to 598       598/598
(100 %)
0 diff
(100 %id)
BP364505 lung GTSE1.b 174 to 754 1 to 582       582/582
(100 %)
1 diff
(99.9 %id)
DA001520   GTSE1.b 175 to 397 2 to 224   capped   223/223
(100 %)
0 diff
(100 %id)
DA024117   GTSE1.b 175 to 742 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
DA454409 tongue, tumor tissue GTSE1.b 175 to 738 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
DA493279 brain GTSE1.b 175 to 747 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA507215 brain GTSE1.b 175 to 728 2 to 554   capped   553/553
(100 %)
1 diff
(99.9 %id)
DA579511   GTSE1.b 175 to 715 2 to 542   capped   541/541
(100 %)
0 diff
(100 %id)
DA643722   GTSE1.b 175 to 719 2 to 546   capped   545/545
(100 %)
0 diff
(100 %id)
DA648848   GTSE1.b 175 to 384 2 to 212   capped   211/211
(100 %)
2 diff
(99.1 %id)
DA656912   GTSE1.b 175 to 746 2 to 573   capped   572/572
(100 %)
4 diff
(99.4 %id)
DA734423   GTSE1.b 175 to 675 2 to 502   capped   501/501
(100 %)
4 diff
(99.3 %id)
DA736086   GTSE1.b 175 to 886 2 to 711   capped   710/710
(100 %)
4 diff
(99.5 %id)
DA851752 placenta GTSE1.b 175 to 754 2 to 581   capped   580/580
(100 %)
0 diff
(100 %id)
DA884985   GTSE1.b 175 to 705 2 to 532   capped   531/531
(100 %)
0 diff
(100 %id)
DA903676   GTSE1.b 175 to 736 2 to 565   capped   564/564
(100 %)
2 diff
(99.7 %id)
DA904239   GTSE1.b 175 to 746 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
DB102552 thymus GTSE1.b 175 to 733 2 to 560   capped   559/559
(100 %)
0 diff
(100 %id)
DB115256 thymus GTSE1.b 175 to 716 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
DB119259 thymus GTSE1.b 175 to 732 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
DB147217 thymus GTSE1.b 175 to 738 2 to 565   capped   564/564
(100 %)
0 diff
(100 %id)
BP380613   GTSE1.b 175 to 784 1 to 610       610/610
(100 %)
4 diff
(99.4 %id)
DW448528 Liver GTSE1.b 177 to 367 17 to 207       191/207
(92 %)
1 diff
(99.6 %id)
DA735774   GTSE1.b 178 to 851 2 to 670   capped   669/669
(100 %)
6 diff
(99.2 %id)
DB119129 thymus GTSE1.b 185 to 723 12 to 551   capped   540/550
(98 %)
7 diff
(98.8 %id)
BQ898308 brain, neuroblastoma, cell line GTSE1.b 190 to 1097 1 to 911       911/913
(99 %)
19 diff
(98.0 %id)
AA306782   GTSE1.b 194 to 668 1 to 475       475/475
(100 %)
1 diff
(99.8 %id)
DN996450 breast cancer, Mammary gland (cancer tissue) GTSE1.b 198 to 894 8 to 703       696/704
(98 %)
7 diff
(99.1 %id)
AA355797   GTSE1.b 199 to 430 1 to 233       233/233
(100 %)
1 diff
(99.6 %id)
AF223408   GTSE1.b 199 to 2827 1 to 2629 V278I W525R AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 2629/2629
(100 %)
2 diff
(100.0 %id)
CN388472 embryonic stem cells, cell lines H1, H7, andH9 GTSE1.b 199 to 830 1 to 632       632/632
(100 %)
3 diff
(99.6 %id)
BQ961804 epithelioid carcinoma cell line, Pancreas GTSE1.b 199 to 1068 1 to 878       876/880
(99 %)
18 diff
(98.0 %id)
BQ064317 lymph, lymphoma, cell line GTSE1.b 200 to 1111 1 to 923       923/1010
(91 %)
24 diff
(97.7 %id)
CN388469 embryonic stem cells, cell lines H1, H7, andH9 GTSE1.b 213 to 937 1 to 725       725/725
(100 %)
1 diff
(99.9 %id)
CN388473 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells GTSE1.b 213 to 882 1 to 671       671/671
(100 %)
1 diff
(99.9 %id)
BF305485 muscle, rhabdomyosarcoma GTSE1.b 221 to 775 1 to 554       554/554
(100 %)
8 diff
(98.6 %id)
BC006325 Muscle, rhabdomyosarcoma GTSE1.b 222 to 3110 1 to 2891   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 2891/2891
(100 %)
3 diff
(99.9 %id)
AI340239 pooled germ cell tumors GTSE1.b 225 to 656 1 to 433     Submitted on the opposite strand 433/433
(100 %)
4 diff
(99.1 %id)
AW131771 brain, medulloblastoma GTSE1.b 225 to 655 1 to 431     Submitted on the opposite strand 431/431
(100 %)
0 diff
(100 %id)
BF002630 colon, colon tumor, RER+ GTSE1.b 233 to 664 1 to 432     Submitted on the opposite strand 432/432
(100 %)
2 diff
(99.6 %id)
AI949012 pooled germ cell tumors GTSE1.b 234 to 659 1 to 426     Submitted on the opposite strand 426/428
(99 %)
5 diff
(98.9 %id)
AI811287 pooled germ cell tumors GTSE1.b 243 to 634 1 to 392     Submitted on the opposite strand 392/392
(100 %)
4 diff
(99.0 %id)
AI657060 pooled germ cell tumors GTSE1.b 243 to 658 1 to 416     Submitted on the opposite strand 416/416
(100 %)
0 diff
(100 %id)
CT841519   GTSE1.b 256 to 2524 1 to 2269       2269/2269
(100 %)
1 diff
(100.0 %id)
AI982562 pooled germ cell tumors GTSE1.b 257 to 624 1 to 368     Submitted on the opposite strand 368/368
(100 %)
2 diff
(99.5 %id)
TI_1948235412   GTSE1.b 263 to 1141 135 to 1018       884/1386
(63 %)
27 diff
(98.1 %id)
TI_1948235447   GTSE1.b 263 to 1235 133 to 1104       973/1345
(72 %)
36 diff
(97.4 %id)
TI_1948235448   GTSE1.b 263 to 979 123 to 840       718/1363
(52 %)
17 diff
(98.8 %id)
TI_1948235484   GTSE1.b 263 to 1141 134 to 1019       886/1390
(63 %)
29 diff
(98.0 %id)
TI_1948235485   GTSE1.b 263 to 896 122 to 756       635/1336
(47 %)
15 diff
(98.9 %id)
TI_1948235519   GTSE1.b 263 to 1141 136 to 1011       876/1355
(64 %)
26 diff
(98.1 %id)
TI_1948235520   GTSE1.b 263 to 1078 121 to 952       832/1341
(62 %)
36 diff
(97.4 %id)
TI_1948244241   GTSE1.b 263 to 1141 134 to 1011       878/1411
(62 %)
14 diff
(99.1 %id)
TI_1948244242   GTSE1.b 263 to 1271 135 to 1139       1005/1258
(79 %)
38 diff
(97.0 %id)
TI_1948244496   GTSE1.b 263 to 1270 133 to 1139       1007/1479
(68 %)
31 diff
(98.0 %id)
TI_1948244497   GTSE1.b 263 to 1185 133 to 1070       938/1329
(70 %)
24 diff
(98.2 %id)
TI_1948244695   GTSE1.b 263 to 1136 124 to 992       869/1434
(60 %)
24 diff
(98.4 %id)
TI_1948244760   GTSE1.b 263 to 1226 131 to 1086   AAA   956/1426
(67 %)
26 diff
(98.2 %id)
TI_1948244761   GTSE1.b 263 to 1262 135 to 1139   AAA   1005/1287
(78 %)
42 diff
(96.8 %id)
TI_1948245024   GTSE1.b 263 to 1187 132 to 1059       928/1419
(65 %)
25 diff
(98.3 %id)
TI_1948245025   GTSE1.b 263 to 1237 132 to 1094       963/1237
(77 %)
29 diff
(97.7 %id)
CU013387 Synthetic constructs GTSE1.b 268 to 2428 19 to 2179       2161/2194
(98 %)
8 diff
(99.7 %id)
CU013099 Synthetic constructs GTSE1.b 268 to 2431 19 to 2182       2164/2197
(98 %)
8 diff
(99.7 %id)
EL733294 mixed GTSE1.b 269 to 923 1 to 653       653/655
(99 %)
4 diff
(99.4 %id)
EL736475 mixed GTSE1.b 269 to 886 1 to 618       618/618
(100 %)
7 diff
(98.9 %id)
AA737929 pooled germ cell tumors GTSE1.b 304 to 647 1 to 344     Submitted on the opposite strand 344/344
(100 %)
4 diff
(98.9 %id)
AI193236 lung GTSE1.b 304 to 581 1 to 278     Submitted on the opposite strand 278/278
(100 %)
0 diff
(100 %id)
BF114652 pooled GTSE1.b 304 to 649 1 to 346     Submitted on the opposite strand 346/346
(100 %)
2 diff
(99.5 %id)
BE900264 choriocarcinoma, placenta GTSE1.b 318 to 1069 1 to 737       737/738
(99 %)
18 diff
(97.6 %id)
AA897181 pooled GTSE1.b 361 to 686 1 to 327     Submitted on the opposite strand 327/327
(100 %)
4 diff
(98.8 %id)
BE501707 Kidney GTSE1.b 378 to 649 1 to 272     Submitted on the opposite strand 272/272
(100 %)
0 diff
(100 %id)
BI195527 brain, neuroblastoma GTSE1.b 438 to 1036 1 to 604       604/604
(100 %)
11 diff
(98.2 %id)
BX353147 Neuroblastoma Cot 25-normalized GTSE1.b 439 to 1521 1 to 1075       1075/1078
(99 %)
17 diff
(98.5 %id)
BX365847 Neuroblastoma Cot 25-normalized GTSE1.b 439 to 1332 1 to 894       894/894
(100 %)
0 diff
(100 %id)
BX370863 Neuroblastoma Cot 25-normalized GTSE1.b 439 to 1330 1 to 891       891/891
(100 %)
2 diff
(99.8 %id)
BX370864 Neuroblastoma Cot 25-normalized GTSE1.b 439 to 1262 1 to 828       828/828
(100 %)
10 diff
(98.8 %id)
BX366236 Neuroblastoma Cot 50-normalized GTSE1.b 439 to 1247 1 to 798       798/885
(90 %)
28 diff
(96.9 %id)
DR762301 embryonic stem GTSE1.b 441 to 1252 13 to 824       812/824
(98 %)
6 diff
(99.3 %id)
BE313296 brain, neuroblastoma GTSE1.b 458 to 1112 1 to 652       652/762
(85 %)
11 diff
(98.6 %id)
BE730157 melanotic melanoma, skin GTSE1.b 509 to 1259 53 to 796       744/797
(93 %)
14 diff
(98.3 %id)
CN388470 embryonic stem cells, cell lines H1, H7, andH9 GTSE1.b 534 to 1056 1 to 523       523/523
(100 %)
1 diff
(99.9 %id)
DB104092 thymus GTSE1.b 639 to 1186 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
BP265503 thyroid GTSE1.b 640 to 1221 1 to 582       582/582
(100 %)
0 diff
(100 %id)
DA731150   GTSE1.b 645 to 1369 2 to 729   capped   728/732
(99 %)
7 diff
(99.1 %id)
BM826303 Ascites, stomach GTSE1.b 666 to 1129 1 to 465       465/465
(100 %)
6 diff
(98.8 %id)
BQ051773 blood, natural killer cells, cell line GTSE1.b 668 to 1644 21 to 1011       991/1090
(90 %)
40 diff
(96.4 %id)
BM564037 blood, natural killer cells, cell line GTSE1.b 671 to 1644 1 to 991       991/1162
(85 %)
58 diff
(95.1 %id)
BQ962337 epithelioid carcinoma cell line, Pancreas GTSE1.b 672 to 1528 1 to 864       864/894
(96 %)
17 diff
(98.1 %id)
DA545159   GTSE1.b 679 to 1247 2 to 570   capped   569/569
(100 %)
1 diff
(99.9 %id)
TI_57186604   GTSE1.b 709 to 1491 55 to 848       794/811
(97 %)
25 diff
(97.0 %id)
BI856977 breast, mammary adenocarcinoma, cell line GTSE1.b 710 to 1491 1 to 793       793/810
(97 %)
25 diff
(97.0 %id)
BX343472 Neuroblastoma Cot 25-normalized GTSE1.b 772 to 1694 1 to 922       922/922
(100 %)
5 diff
(99.5 %id)
BX349470 Neuroblastoma Cot 25-normalized GTSE1.b 772 to 1457 1 to 686       686/839
(81 %)
15 diff
(98.3 %id)
BX354424 Neuroblastoma Cot 25-normalized GTSE1.b 772 to 1611 1 to 839       839/839
(100 %)
5 diff
(99.5 %id)
BX349469 Neuroblastoma Cot 25-normalized GTSE1.b 973 to 1694 721 to 1       721/721
(100 %)
42 diff
(94.2 %id)
CK000378 mixed GTSE1.b 1025 to 1687 1 to 661       661/661
(100 %)
6 diff
(99.1 %id)
BE336704 Kidney, renal cell adenocarcinoma GTSE1.b 1082 to 1593 1 to 513       513/514
(99 %)
2 diff
(99.7 %id)
AI346898 adenocarcinoma, colon GTSE1.b 1137 to 1676 540 to 1       540/540
(100 %)
1 diff
(99.9 %id)
CN333995 embryonic stem cells, cell lines H1, H7, andH9 GTSE1.b 1138 to 1786 1 to 649       649/649
(100 %)
1 diff
(99.9 %id)
AA776790   GTSE1.b 1179 to 1664 487 to 1       487/497
(97 %)
3 diff
(99.4 %id)
AA765941 germinal center B cell GTSE1.b 1195 to 1609 415 to 1       415/415
(100 %)
4 diff
(99.1 %id)
BG761202 melanotic melanoma, high MDR (cell line), skin GTSE1.b 1199 to 2055 1 to 864       864/1121
(77 %)
18 diff
(98.4 %id)
AI864049 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) GTSE1.b 1211 to 1664 454 to 1       454/454
(100 %)
1 diff
(99.8 %id)
AI204575 lung GTSE1.b 1212 to 1664 453 to 1       453/453
(100 %)
0 diff
(100 %id)
AW001884 thymus, pooled GTSE1.b 1218 to 1664 447 to 1       445/447
(99 %)
7 diff
(98.5 %id)
AI199724 anaplastic oligodendroglioma, brain GTSE1.b 1219 to 1676 458 to 1       458/458
(100 %)
0 diff
(100 %id)
AA814396 germinal center B cell GTSE1.b 1232 to 1609 378 to 1       378/383
(98 %)
1 diff
(99.8 %id)
AA806504 germinal center B cell GTSE1.b 1232 to 1609 378 to 1       378/383
(98 %)
2 diff
(99.5 %id)
AA687396 germinal center B cell GTSE1.b 1261 to 1669 409 to 1       409/415
(98 %)
1 diff
(99.8 %id)
AA972001 pooled GTSE1.b 1277 to 1641 365 to 1       365/365
(100 %)
4 diff
(99.0 %id)
BX368566 Neuroblastoma Cot 25-normalized GTSE1.b 1287 to 1694 1 to 404       404/404
(100 %)
5 diff
(98.8 %id)
AA297142 uterus GTSE1.b 1321 to 1491 171 to 1     Submitted on the opposite strand 171/171
(100 %)
1 diff
(99.5 %id)
BU849532 ovary, teratocarcinoma, cell line GTSE1.b 1324 to 2130 1 to 810       810/887
(91 %)
18 diff
(98.0 %id)
AW593470 pooled germ cell tumors GTSE1.b 1332 to 1662 331 to 1       331/331
(100 %)
0 diff
(100 %id)
BF512336   GTSE1.b 1430 to 1693 264 to 1       264/264
(100 %)
1 diff
(99.7 %id)
TI_1948244763   GTSE1.b 1444 to 2430 1120 to 129       992/1423
(69 %)
39 diff
(97.3 %id)
TI_1948235486   GTSE1.b 1448 to 2430 1111 to 113       1001/1246
(80 %)
50 diff
(96.0 %id)
TI_1948244243   GTSE1.b 1448 to 2430 1121 to 127       995/1175
(84 %)
29 diff
(97.6 %id)
TI_1948245027   GTSE1.b 1463 to 2430 1087 to 128       960/1369
(70 %)
47 diff
(96.6 %id)
TI_1948244762   GTSE1.b 1472 to 2430 1098 to 123       976/1195
(81 %)
37 diff
(97.0 %id)
TI_1948244244   GTSE1.b 1524 to 2430 1044 to 128       915/1425
(64 %)
32 diff
(97.8 %id)
TI_1948244498   GTSE1.b 1557 to 2430 1010 to 126       885/1210
(73 %)
26 diff
(97.9 %id)
TI_1948245026   GTSE1.b 1563 to 2430 995 to 127       869/1202
(72 %)
6 diff
(99.6 %id)
TI_1948235449   GTSE1.b 1565 to 2430 992 to 122       871/1266
(68 %)
29 diff
(97.8 %id)
TI_1948235415   GTSE1.b 1634 to 2430 922 to 122       801/1264
(63 %)
14 diff
(98.9 %id)
TI_1948244499   GTSE1.b 1634 to 2430 928 to 130       799/1445
(55 %)
12 diff
(99.2 %id)
AA478055 ovarian tumor, ovary GTSE1.b 1687 to 2114 1 to 428     Submitted on the opposite strand 428/428
(100 %)
2 diff
(99.6 %id)
AI369284 anaplastic oligodendroglioma, brain GTSE1.b 1687 to 2174 1 to 488     Submitted on the opposite strand 488/488
(100 %)
1 diff
(99.8 %id)
AW131563 brain, medulloblastoma GTSE1.b 1687 to 2428 1 to 742     Submitted on the opposite strand 742/742
(100 %)
5 diff
(99.4 %id)
AW575675 lymph GTSE1.b 1688 to 1992 1 to 305     Submitted on the opposite strand 305/305
(100 %)
1 diff
(99.7 %id)
TI_1948235522   GTSE1.b 1704 to 2430 767 to 38       730/1216
(60 %)
21 diff
(98.3 %id)
AI970127 pooled germ cell tumors GTSE1.b 1709 to 2310 1 to 603     Submitted on the opposite strand 603/603
(100 %)
9 diff
(98.6 %id)
AI049849   GTSE1.b 1710 to 2109 5 to 404     Submitted on the opposite strand 400/404
(99 %)
6 diff
(98.6 %id)
AI871402 anaplastic oligodendroglioma, brain GTSE1.b 1710 to 2255 10 to 555     Submitted on the opposite strand 546/555
(98 %)
6 diff
(99.0 %id)
AW079575 colon, moderately differentiated adenocarcinoma GTSE1.b 1714 to 1994 1 to 283     Submitted on the opposite strand 283/283
(100 %)
5 diff
(98.3 %id)
AA651808 germinal center B cell GTSE1.b 1723 to 2029 1 to 307     Submitted on the opposite strand 307/307
(100 %)
4 diff
(98.7 %id)
TI_1948235418   GTSE1.b 1723 to 2430 863 to 149       715/1329
(53 %)
74 diff
(94.5 %id)
AA312804   GTSE1.b 1755 to 2161 1 to 408       408/408
(100 %)
2 diff
(99.6 %id)
AW965808   GTSE1.b 1756 to 2429 1 to 673       673/673
(100 %)
11 diff
(98.4 %id)
TI_1948235521   GTSE1.b 1808 to 2430 767 to 138       630/1449
(43 %)
15 diff
(99.0 %id)
TI_1948235426   GTSE1.b 1828 to 2430 758 to 154       605/1390
(43 %)
6 diff
(99.6 %id)
CN388471 embryonic stem cells, DMSO-treated H9 cellline GTSE1.b 1837 to 2499 1 to 664       664/664
(100 %)
2 diff
(99.7 %id)
BM788057 stomach GTSE1.b 1850 to 2317 1 to 468       468/468
(100 %)
0 diff
(100 %id)
DA436881 tongue, tumor tissue GTSE1.b 1854 to 2429 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
BE786449 large cell carcinoma, lung GTSE1.b 1916 to 2625 1 to 702       702/757
(92 %)
20 diff
(97.4 %id)
BF973178 leiomyosarcoma cell line, uterus GTSE1.b 1934 to 2756 698 to 1     Submitted on the opposite strand 600/1114
(53 %)
18 diff
(98.4 %id)
BQ683005 melanotic melanoma, cell line, skin GTSE1.b 1955 to 2803 1 to 863       863/889
(97 %)
29 diff
(96.8 %id)
BX375130 Neuroblastoma Cot 25-normalized GTSE1.b 2034 to 3120 1 to 1077   tiling clone,   1077/1106
(97 %)
18 diff
(98.4 %id)
N36531 melanocyte GTSE1.b 2054 to 2388 1 to 334       334/334
(100 %)
1 diff
(99.8 %id)
BG033836 breast, mammary adenocarcinoma, cell line GTSE1.b 2089 to 2837 1 to 750       750/753
(99 %)
22 diff
(97.1 %id)
CX755625 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass GTSE1.b 2154 to 2881 1 to 722     Submitted on the opposite strand 722/724
(99 %)
8 diff
(98.9 %id)
CX755899 Blastocyst, pluripotent cell line derived fromblastocyst inner cell mass GTSE1.b 2157 to 2871 1 to 710     Submitted on the opposite strand 710/710
(100 %)
8 diff
(98.9 %id)
BX114954 ovarian tumor, ovary GTSE1.b 2172 to 2782 627 to 17   AAA Submitted on the opposite strand 611/613
(99 %)
0 diff
(100 %id)
BI861735 breast, mammary adenocarcinoma, cell line GTSE1.b 2189 to 2802 1 to 616       616/617
(99 %)
5 diff
(99.2 %id)
TI_57193120   GTSE1.b 2189 to 2802 47 to 662       616/804
(76 %)
5 diff
(99.4 %id)
DB363235   GTSE1.b 2202 to 2785 581 to 1       581/581
(100 %)
17 diff
(97.1 %id)
BG109292 Bone, osteosarcoma, cell line GTSE1.b 2219 to 2976 1 to 755       755/784
(96 %)
29 diff
(96.4 %id)
DB366166   GTSE1.b 2219 to 2785 574 to 1       572/580
(98 %)
16 diff
(97.3 %id)
CN388474 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells GTSE1.b 2221 to 2782 26 to 587       562/587
(95 %)
6 diff
(99.0 %id)
DB326847 brain GTSE1.b 2257 to 2785 529 to 1       529/529
(100 %)
1 diff
(99.9 %id)
DB347037 thymus GTSE1.b 2261 to 2785 525 to 1       525/525
(100 %)
0 diff
(100 %id)
DB368513   GTSE1.b 2282 to 2785 505 to 1       505/505
(100 %)
5 diff
(99.1 %id)
DB368117   GTSE1.b 2286 to 2785 499 to 1       499/503
(99 %)
2 diff
(99.7 %id)
CX871575 embryonic stem GTSE1.b 2288 to 3095 808 to 1   tiling clone, Submitted on the opposite strand 808/808
(100 %)
0 diff
(100 %id)
BE206174 Kidney, renal cell adenocarcinoma GTSE1.b 2303 to 2787 485 to 1       485/485
(100 %)
1 diff
(99.8 %id)
AA707075 liver and spleen GTSE1.b 2318 to 2618 301 to 1       301/302
(99 %)
0 diff
(100 %id)
AA602632 adrenal adenoma, adrenal gland GTSE1.b 2322 to 2785 461 to 1       461/461
(100 %)
3 diff
(99.4 %id)
TI_154145845   GTSE1.b 2344 to 3035 769 to 79     Submitted on the opposite strand 691/819
(84 %)
48 diff
(94.2 %id)
AA872687 pooled germ cell tumors GTSE1.b 2408 to 2785 377 to 1       377/377
(100 %)
4 diff
(99.0 %id)
CX166789 human embryonic stem cells differentiated toan early endodermal cell type GTSE1.b 2418 to 3108 717 to 27   AAA Submitted on the opposite strand 691/691
(100 %)
4 diff
(99.5 %id)
DA755979   GTSE1.b 2453 to 3009 2 to 558   capped   557/557
(100 %)
0 diff
(100 %id)
AA618537 lung, lung tumor GTSE1.b 2497 to 2785 288 to 1       288/288
(100 %)
1 diff
(99.7 %id)
AW958002   GTSE1.b 2504 to 2785 1 to 282   AAA Possibly primed on the genome, locally A rich (13/13 A in genome downstream of last aligned base) 282/282
(100 %)
2 diff
(99.3 %id)
AA825215 germinal center B cell GTSE1.b 2519 to 2794 275 to 1       275/275
(100 %)
1 diff
(99.7 %id)
BP284070 bone marrow GTSE1.c 1 to 583 2 to 584   tiling clone,   584/587
(99 %)
6 diff
(99.0 %id)
BP352671   GTSE1.c 1 to 603 2 to 603       603/608
(99 %)
7 diff
(98.9 %id)
DC406086 thymus GTSE1.c 25 to 581 1 to 557       557/557
(100 %)
0 diff
(100 %id)
AK303087 thymus GTSE1.c 28 to 2556 1 to 2528 W457R tiling clone,   2528/2528
(100 %)
2 diff
(100.0 %id)
DC404851 thymus GTSE1.c 28 to 583 1 to 555       555/555
(100 %)
1 diff
(99.9 %id)
DW412460 Liver GTSE1.c 29 to 338 10 to 324       310/324
(95 %)
9 diff
(97.3 %id)
DC405219 thymus GTSE1.c 30 to 607 1 to 578       578/578
(100 %)
2 diff
(99.7 %id)
DC405341 thymus GTSE1.c 30 to 604 1 to 575       575/575
(100 %)
0 diff
(100 %id)
DC424522 ovary, tumor tissue GTSE1.c 31 to 772 1 to 748       748/749
(99 %)
22 diff
(97.1 %id)
DW456843 Liver GTSE1.c 32 to 180 18 to 166       144/166
(86 %)
7 diff
(95.8 %id)
DC350643 brain GTSE1.c 32 to 567 1 to 536       536/536
(100 %)
1 diff
(99.9 %id)
DC357990   GTSE1.c 32 to 578 1 to 547       547/547
(100 %)
0 diff
(100 %id)
DC424422   GTSE1.c 32 to 888 1 to 870       870/875
(99 %)
22 diff
(97.5 %id)
DC371821   GTSE1.c 32 to 570 1 to 539       539/539
(100 %)
0 diff
(100 %id)
DC386485   GTSE1.c 32 to 590 1 to 559       559/559
(100 %)
1 diff
(99.9 %id)
BP352185   GTSE1.c 32 to 612 1 to 581       581/581
(100 %)
0 diff
(100 %id)
BP352483   GTSE1.c 32 to 610 1 to 582       582/582
(100 %)
2 diff
(99.7 %id)
BP352520   GTSE1.c 32 to 624 1 to 592       592/592
(100 %)
3 diff
(99.5 %id)
DC406507 thymus GTSE1.c 32 to 592 1 to 561       561/561
(100 %)
0 diff
(100 %id)
BG761585 melanotic melanoma, high MDR (cell line), skin GTSE1.c 34 to 604 1 to 574       574/574
(100 %)
9 diff
(98.5 %id)
BG768450 melanotic melanoma, high MDR (cell line), skin GTSE1.c 34 to 495 1 to 466       466/466
(100 %)
5 diff
(99.0 %id)
DC424316   GTSE1.c 34 to 555 1 to 522       522/522
(100 %)
5 diff
(99.1 %id)
DC348615   GTSE1.c 37 to 606 1 to 570       570/570
(100 %)
1 diff
(99.9 %id)
BG769753 melanotic melanoma, high MDR (cell line), skin GTSE1.c 41 to 818 7 to 780       774/780
(99 %)
17 diff
(97.9 %id)
BG828492 muscle, rhabdomyosarcoma GTSE1.c 51 to 937 1 to 901       877/957
(91 %)
36 diff
(96.3 %id)
DC427237   GTSE1.c 2025 to 2585 562 to 1       562/563
(99 %)
6 diff
(99.0 %id)
DC427162   GTSE1.c 2026 to 2585 566 to 1       566/583
(97 %)
21 diff
(96.4 %id)
DC427314 ovary, tumor tissue GTSE1.c 2035 to 2585 552 to 1       552/580
(95 %)
22 diff
(96.3 %id)
BX346474 Neuroblastoma Cot 25-normalized GTSE1.c 2302 to 3261 1 to 951   tiling clone,   951/1019
(93 %)
33 diff
(96.8 %id)
DB340823 testis GTSE1.c 2371 to 2908 538 to 1       538/538
(100 %)
0 diff
(100 %id)
AA478217 ovarian tumor, ovary GTSE1.c 2385 to 2585 201 to 1     Submitted on the opposite strand 201/201
(100 %)
0 diff
(100 %id)
AA641760 germinal center B cell GTSE1.c 2413 to 2844 432 to 1     Submitted on the opposite strand 432/432
(100 %)
2 diff
(99.6 %id)
TI_154147093   GTSE1.c 2427 to 2835 494 to 85     Submitted on the opposite strand 410/411
(99 %)
3 diff
(99.3 %id)
DB522754 testis GTSE1.c 2436 to 2908 1 to 473     Submitted on the opposite strand 473/473
(100 %)
2 diff
(99.6 %id)
DB518214 testis GTSE1.c 2480 to 2908 1 to 430     Submitted on the opposite strand 430/430
(100 %)
1 diff
(99.8 %id)
AI283080 placenta GTSE1.c 2517 to 2911 402 to 8       395/402
(98 %)
0 diff
(100 %id)
AA706775 liver and spleen GTSE1.c 2542 to 2861 320 to 1       320/320
(100 %)
1 diff
(99.7 %id)
AI039383   GTSE1.c 2542 to 2897 361 to 6       356/361
(98 %)
0 diff
(100 %id)
AA865479 pooled germ cell tumors GTSE1.c 2543 to 2911 374 to 6       369/374
(98 %)
0 diff
(100 %id)
CB115007 Liver GTSE1.c 2576 to 3161 1 to 585       585/585
(100 %)
1 diff
(99.9 %id)
DB528349 hippocampus GTSE1.c 2577 to 2910 1 to 334     Submitted on the opposite strand 334/334
(100 %)
4 diff
(98.9 %id)
AI298140 placenta GTSE1.c 2582 to 2911 335 to 6       330/335
(98 %)
0 diff
(100 %id)
BX326778 Neuroblastoma Cot 25-normalized GTSE1.c 2589 to 3492 1 to 907       907/907
(100 %)
18 diff
(98.1 %id)
BX326777 Neuroblastoma Cot 25-normalized GTSE1.c 2590 to 3471 1 to 886       886/886
(100 %)
24 diff
(97.3 %id)
AI198867   GTSE1.c 2590 to 2910 354 to 34   AAA   321/321
(100 %)
3 diff
(99.1 %id)
BX390160 Neuroblastoma Cot 25-normalized GTSE1.c 2592 to 3510 1 to 916       916/919
(99 %)
16 diff
(98.3 %id)
AI910562 pooled GTSE1.c 2606 to 2911 308 to 3       306/317
(96 %)
0 diff
(100 %id)
AA306242   GTSE1.c 2613 to 2990 1 to 378       378/379
(99 %)
1 diff
(99.8 %id)
DB512359 testis GTSE1.c 2617 to 2908 1 to 292     Submitted on the opposite strand 292/292
(100 %)
10 diff
(96.6 %id)
AA884354 pooled GTSE1.c 2639 to 2911 276 to 5       272/276
(98 %)
0 diff
(100 %id)
AA905848 pooled GTSE1.c 2639 to 2911 277 to 5       273/277
(98 %)
0 diff
(100 %id)
AA682713 liver and spleen GTSE1.c 2649 to 2910 280 to 15       266/280
(95 %)
0 diff
(100 %id)
CB105827 Liver GTSE1.c 2650 to 2910 1 to 261   AAA   261/261
(100 %)
1 diff
(99.7 %id)
CB105854 Liver GTSE1.c 2650 to 2910 1 to 261   AAA   261/261
(100 %)
1 diff
(99.7 %id)
CN333996 embryonic stem cells, DMSO-treated H9 cellline GTSE1.c 2669 to 3457 1 to 790       790/790
(100 %)
1 diff
(99.9 %id)
DB529202 hippocampus GTSE1.c 2672 to 2910 1 to 239     Submitted on the opposite strand 239/239
(100 %)
6 diff
(97.5 %id)
BQ049956 lymph, lymphoma, cell line GTSE1.c 2701 to 3368 1 to 678       678/1279
(53 %)
16 diff
(98.8 %id)
BI253942 cervical carcinoma cell line, cervix GTSE1.c 2706 to 3129 1 to 424       424/424
(100 %)
3 diff
(99.3 %id)
BM917306 blood, natural killer cells, cell line GTSE1.c 2706 to 3230 1 to 525       525/1451
(36 %)
13 diff
(99.2 %id)
BQ054173 blood, natural killer cells, cell line GTSE1.c 2707 to 3634 1 to 946       946/1046
(90 %)
22 diff
(97.9 %id)
EH339547   GTSE1.c 2714 to 2798 1 to 85       85/85
(100 %)
0 diff
(100 %id)
CB160097 Liver GTSE1.c 2804 to 3365 1 to 562       562/562
(100 %)
1 diff
(99.9 %id)
DB152041 thymus GTSE1.c 2880 to 3477 2 to 599   capped   598/598
(100 %)
0 diff
(100 %id)
BM749515 stomach GTSE1.c 2885 to 3481 1 to 595       595/595
(100 %)
3 diff
(99.5 %id)
BM763558 myeloma GTSE1.c 2889 to 3369 1 to 481       481/484
(99 %)
3 diff
(99.4 %id)
CN333997 embryonic stem cells, DMSO-treated H9 cellline GTSE1.c 2911 to 3613 1 to 703   tiling clone,   703/703
(100 %)
1 diff
(99.9 %id)
TI_154185692   GTSE1.c 2914 to 3760 115 to 948       834/983
(84 %)
22 diff
(97.8 %id)
BE537470 cervix GTSE1.c 2929 to 3251 1 to 325       325/325
(100 %)
4 diff
(98.8 %id)
BM793258 Ascites, stomach GTSE1.c 2953 to 3448 1 to 496       496/496
(100 %)
0 diff
(100 %id)
BM835752 stomach GTSE1.c 2963 to 3575 1 to 613       613/613
(100 %)
2 diff
(99.7 %id)
BF305380 muscle, rhabdomyosarcoma GTSE1.c 3516 to 4135 1 to 619   tiling clone, available from MGC,   619/689
(89 %)
5 diff
(99.3 %id)
BC021234 Muscle, rhabdomyosarcoma GTSE1.c 3517 to 4109 1 to 593   available from MGC, AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 593/593
(100 %)
0 diff
(100 %id)
AY927427   GTSE1.d 1 to 1111 9 to 1119 W173R tiling clone,   1111/1120
(99 %)
9 diff
(99.2 %id)
BE792063 lung, small cell carcinoma GTSE1.d 389 to 1102 1 to 710       710/710
(100 %)
7 diff
(99.1 %id)
BX644932   GTSE1.d 413 to 1068 1 to 656       656/656
(100 %)
1 diff
(99.9 %id)
BF589388 pooled GTSE1.d 443 to 969 6 to 532     Submitted on the opposite strand 527/532
(99 %)
7 diff
(98.7 %id)
CX872667 embryonic stem GTSE1.d 904 to 1581 1 to 678   tiling clone,   678/678
(100 %)
0 diff
(100 %id)
AY927425   GTSE1.d 1087 to 1654 1 to 568   tiling clone,   568/569
(99 %)
5 diff
(99.2 %id)
AY927426   GTSE1.e 1 to 1330 9 to 1338 W173R R217C tiling clone,   1330/1338
(99 %)
10 diff
(99.3 %id)
AA459253 germinal center B cell GTSE1.e 419 to 805 1 to 386   tiling clone, Submitted on the opposite strand 386/386
(100 %)
3 diff
(99.3 %id)
AA912971 pooled GTSE1.e 421 to 889 1 to 464     Submitted on the opposite strand 464/464
(100 %)
8 diff
(98.3 %id)
AW972282   GTSE1.e 791 to 1310 105 to 624       520/624
(83 %)
7 diff
(98.9 %id)
AA494075 liposarcoma GTSE1.e 804 to 1216 1 to 412       412/412
(100 %)
3 diff
(99.3 %id)
CN267548 embryonic stem cells, cell lines H1, H7, andH9 GTSE1.e 805 to 1498 1 to 694   tiling clone,   694/694
(100 %)
5 diff
(99.3 %id)
BI117388 lung, small cell carcinoma GTSE1.f 1 to 899 1 to 892   tiling clone,   892/967
(92 %)
41 diff
(95.8 %id)
AA463557   GTSE1.f 573 to 828 1 to 252   tiling clone, fully sequenced,   252/252
(100 %)
8 diff
(96.9 %id)
AI038747   GTSE1.f 666 to 1139 474 to 1   tiling clone,   474/474
(100 %)
6 diff
(98.8 %id)
AI039394   GTSE1.f 704 to 1139 434 to 1       434/434
(100 %)
7 diff
(98.4 %id)
AA463508   GTSE1.f 798 to 1139 342 to 1   tiling clone, fully sequenced,   342/342
(100 %)
3 diff
(99.2 %id)
DW412654 Liver GTSE1.g -9 to 304 15 to 323   tiling clone,   309/323
(95 %)
7 diff
(97.9 %id)
DW410861 Liver GTSE1.g 3 to 322 18 to 332       315/332
(94 %)
10 diff
(97.0 %id)
DW465075 Liver GTSE1.g 3 to 350 18 to 360       343/360
(95 %)
7 diff
(98.1 %id)
DA049751   GTSE1.g 13 to 554 2 to 543   capped   542/542
(100 %)
0 diff
(100 %id)
DA508148 brain GTSE1.g 14 to 593 2 to 581 V53X tiling clone, capped   580/580
(100 %)
0 diff
(100 %id)
AW967984   GTSE1.h 1 to 717 723 to 6   tiling clone, Submitted on the opposite strand 718/726
(98 %)
0 diff
(100 %id)
AA262839 germinal center B cell GTSE1.h 3 to 384 9 to 391   tiling clone, fully sequenced,   383/391
(97 %)
1 diff
(99.8 %id)
CN288120 embryonic stem cells, cell lines H1, H7, andH9 GTSE1.h 19 to 426 1 to 409       409/409
(100 %)
4 diff
(99.1 %id)
AA766703 germinal center B cell GTSE1.h 297 to 675 379 to 1       379/379
(100 %)
0 diff
(100 %id)
AA262759 germinal center B cell GTSE1.h 354 to 715 363 to 1   fully sequenced,   363/363
(100 %)
6 diff
(98.4 %id)
BI020662 marrow GTSE1.h 555 to 1018 1 to 464   tiling clone,   464/464
(100 %)
9 diff
(98.1 %id)
BI020118 marrow GTSE1.h 559 to 1124 1 to 566   tiling clone,   566/579
(97 %)
3 diff
(99.5 %id)
BG951430 colon GTSE1.i 1 to 271 10 to 278   tiling clone,   269/288
(93 %)
3 diff
(99.0 %id)
AI198991 anaplastic oligodendroglioma, brain GTSE1.i 239 to 634 395 to 1   tiling clone,   395/395
(100 %)
7 diff
(98.3 %id)
DA737312   GTSE1.j 1 to 776 2 to 783 G107W R108X tiling clone, capped   782/790
(98 %)
10 diff
(98.8 %id)
DA736464   GTSE1.k 1 to 856 2 to 855   tiling clone, capped   854/854
(100 %)
10 diff
(98.9 %id)
R60417 whole brain GTSE1.k 523 to 911 1 to 390   tiling clone, Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 390/390
(100 %)
3 diff
(99.3 %id)
Z45766 brain, total brain GTSE1.k 794 to 1042 1 to 249       249/249
(100 %)
0 diff
(100 %id)
DA910044   GTSE1.k 798 to 1369 2 to 573   capped   572/572
(100 %)
1 diff
(99.9 %id)
BG770679 melanotic melanoma, high MDR (cell line), skin GTSE1.k 804 to 1487 1 to 697       697/697
(100 %)
20 diff
(97.2 %id)
BG768536 melanotic melanoma, high MDR (cell line), skin GTSE1.k 804 to 1587 1 to 791   available from MGC,   791/888
(89 %)
24 diff
(97.3 %id)
BC069212 Skin, melanotic melanoma, high MDR. GTSE1.k 805 to 2277 1 to 1474 V17G T18D S19L L20P L21P ... tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 1474/1474
(100 %)
4 diff
(99.8 %id)
DB013951 esophageal, tumor tissue GTSE1.k 834 to 1404 2 to 572   capped   571/572
(99 %)
1 diff
(99.9 %id)
DA617526   GTSE1.k 847 to 1416 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
AA341513 Kidney GTSE1.k 967 to 1220 1 to 256       256/256
(100 %)
2 diff
(99.3 %id)
BE390871 endometrium, adenocarcinoma cell line, uterus GTSE1.k 1077 to 1743 1 to 660 R7P M9T G15A P16C V17D ...     660/670
(98 %)
18 diff
(97.4 %id)
BG032769 breast, mammary adenocarcinoma, cell line GTSE1.k 1129 to 1808 57 to 726 R7V S8H M9E S10Q S11*     670/967
(69 %)
24 diff
(97.6 %id)
BI222751 cervical carcinoma cell line, cervix GTSE1.k 1230 to 1932 1 to 702 L33S S34P C35V W36G     702/702
(100 %)
2 diff
(99.8 %id)
CX866545 embryonic stem GTSE1.k 1349 to 2171 9 to 830 exact tiling clone,   822/830
(99 %)
6 diff
(99.3 %id)
BX329502 Neuroblastoma Cot 25-normalized GTSE1.k 1367 to 2272 907 to 1 exact     907/907
(100 %)
37 diff
(96.0 %id)
BE154567 head_neck GTSE1.k 1401 to 1989 3 to 589 M9T     587/589
(99 %)
10 diff
(98.4 %id)
BE154582 head_neck GTSE1.k 1401 to 1976 15 to 589 M9T     575/589
(97 %)
14 diff
(97.7 %id)
BE154463 head_neck GTSE1.k 1417 to 2064 1 to 647 M9T     647/662
(97 %)
19 diff
(97.2 %id)
AW383013 head_neck GTSE1.k 1461 to 2084 621 to 1 M9T     621/624
(99 %)
13 diff
(98.0 %id)
CF272279 Brain glioblastoma GTSE1.k 1466 to 2391 945 to 1 K2S M9H S10E S11Q D12*   Submitted on the opposite strand 945/997
(94 %)
26 diff
(97.4 %id)
AW960916   GTSE1.k 1492 to 2269 657 to 8 E4K T18P S19P L20S L21C ...   Submitted on the opposite strand 548/657
(83 %)
27 diff
(95.9 %id)
BE154494 head_neck GTSE1.k 1493 to 2084 590 to 1 M9T L33F   Submitted on the opposite strand 590/591
(99 %)
9 diff
(98.5 %id)
BE154575 head_neck GTSE1.k 1499 to 2095 604 to 10 M9T W36R   Submitted on the opposite strand 595/606
(98 %)
3 diff
(99.6 %id)
BE154442 head_neck GTSE1.k 1504 to 2095 595 to 4 M9T S13P   Submitted on the opposite strand 592/595
(99 %)
10 diff
(98.4 %id)
BF033278 adenocarcinoma, ovary GTSE1.k 1505 to 2117 1 to 642 D12*     600/694
(86 %)
43 diff
(93.9 %id)
BU621031 cell lines, Chondrosarcoma GTSE1.k 1543 to 2277 749 to 19 K2P P3E E4N K5P P6L ... AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 731/738
(99 %)
5 diff
(99.4 %id)
BU632614 cell lines, Chondrosarcoma GTSE1.k 1574 to 2277 722 to 19 exact AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 704/704
(100 %)
1 diff
(99.9 %id)
CA419902 Bone, Human Chondrosarcoma Cell Line GTSE1.k 1674 to 2277 622 to 19   AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 604/604
(100 %)
0 diff
(100 %id)
BG185001   GTSE1.k 1689 to 2056 1 to 368       368/368
(100 %)
5 diff
(98.7 %id)
DB368946   GTSE1.k 1755 to 2269 524 to 9       516/524
(98 %)
0 diff
(100 %id)
AI925151 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus GTSE1.k 1778 to 2277 500 to 1       500/500
(100 %)
1 diff
(99.8 %id)
BF593815 brain, glioblastoma (pooled) GTSE1.k 1798 to 2269 480 to 9       472/480
(98 %)
0 diff
(100 %id)
AW028073 brain, glioblastoma (pooled) GTSE1.k 1806 to 2269 472 to 9       464/472
(98 %)
0 diff
(100 %id)
AI423032 brain, glioblastoma (pooled) GTSE1.k 1838 to 2269 440 to 9       432/440
(98 %)
0 diff
(100 %id)
AA723891 pooled GTSE1.k 1843 to 2278 435 to 1       435/435
(100 %)
1 diff
(99.8 %id)
AW027230 thymus, pooled GTSE1.k 1847 to 2278 432 to 1       432/432
(100 %)
2 diff
(99.6 %id)
R60358 whole brain GTSE1.k 1855 to 2277 440 to 13   AAA Possibly primed on the genome, locally A rich (10/11 A in genome downstream of last aligned base) 428/437
(97 %)
11 diff
(97.5 %id)
AA693985 liver and spleen GTSE1.k 1861 to 2277 417 to 1       417/417
(100 %)
1 diff
(99.8 %id)
DB331399   GTSE1.k 1881 to 2407 527 to 1   tiling clone,   527/529
(99 %)
0 diff
(100 %id)
AA699928 liver and spleen GTSE1.k 1914 to 2277 364 to 1       364/364
(100 %)
1 diff
(99.8 %id)
F03050 brain, total brain GTSE1.k 1928 to 2277 350 to 1       350/350
(100 %)
1 diff
(99.8 %id)
AI476102 lymph node, lymphoma, follicular mixed small and largecell GTSE1.k 1935 to 2278 344 to 1       344/344
(100 %)
0 diff
(100 %id)
F04638 brain, total brain GTSE1.k 1997 to 2277 281 to 1       281/281
(100 %)
1 diff
(99.7 %id)
AA725531   GTSE1.k 2098 to 2280 183 to 1       183/183
(100 %)
0 diff
(100 %id)
AL135664 melanoma (MeWo cell line) GTSE1.k 2183 to 2684 1 to 502   tiling clone,   502/504
(99 %)
1 diff
(99.9 %id)
BU856009 ovary, teratocarcinoma, cell line GTSE1.l-u 1 to 841 1 to 858 Q2* tiling clone,   858/906
(94 %)
35 diff
(96.2 %id)
AA663532   GTSE1.l-u 200 to 395 1 to 196     Submitted on the opposite strand 196/196
(100 %)
0 diff
(100 %id)
DB164023 thymus GTSE1.m-u 1 to 603 2 to 602 exact tiling clone, capped   601/601
(100 %)
1 diff
(99.9 %id)
DB109576 thymus GTSE1.n-u 1 to 585 2 to 585 exact tiling clone, capped   584/584
(100 %)
1 diff
(99.9 %id)
DC428314   GTSE1.o 1 to 566 6 to 571 exact tiling clone,   571/571
(100 %)
0 diff
(100 %id)
DA799074 brain GTSE1.p-u 1 to 513 2 to 515 exact tiling clone, capped   514/514
(100 %)
2 diff
(99.7 %id)
AA805716 germinal center B cell GTSE1.q 1 to 471 1 to 467 W10R R11H R22L C23L S24W ... tiling clone, Submitted on the opposite strand 467/467
(100 %)
5 diff
(99.0 %id)
BG207711   GTSE1.r 1 to 454 1 to 454 exact tiling clone,   454/454
(100 %)
1 diff
(99.8 %id)
76 other accessions, mainly redundant or of lesser quality, also belong to this gene but are not reported.
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l-u, .m-u, .n-u, .o, .p-u, .q, .r Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI